Asthma Treatment Market Insights, Competitive Landscape, and Forecast 2023-2030: Short-Acting Bronchodilators Dominate the $23.9 Billion Industry, Albuterol and Levalbuterol Lead in Treatments Dublin, July 25, 2024 (GLOBE NEWSWIRE) -- The "Asthma Treatment - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The...

Anti-Asthmatics And COPD Drugs Global Market Report 2023: A $117.36 Billion Market by 2027 Featuring Novartis, Merck, GSK, Boehringer Ingelheim, AstraZeneca, Roche, Teva, Vectura, Pfizer and Abbott Dublin, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The "Anti-Asthmatics And COPD Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.Major players in the...

Global Anti-Asthmatics and COPD Drugs Markets Report 2021: Top 10 in Sales are Ellipta, Symbicort, Spiriva, Advair, Nucala, Xolair, Ventolin, Pulmicort, Fasenra, Flovent Dublin, Dec. 09, 2021 (GLOBE NEWSWIRE) -- The "Anti-Asthmatics and COPD Drugs Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth" report has been added to...

Global Anti-Asthmatics and COPD Drugs Market Report 2021 with Focus on COVID-19 Impacts - Major Players are Novartis AG, Merck & Co, GlaxoSmithKline, Boehringer Ingelheim and AstraZeneca Dublin, May 21, 2021 (GLOBE NEWSWIRE) -- The "Anti-Asthmatics and COPD Drugs Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's...

World Anti-Asthmatics and COPD Drugs Market Analysis and Forecasts 2020-2030, with COVID-19 Implications and Growth Forecasts Dublin, Sept. 15, 2020 (GLOBE NEWSWIRE) -- The "Anti-Asthmatics and COPD Drugs Global Market Report 2020-30: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com's...